119th Congress · HOUSE RESOLUTIONBILL

H.Res. 1285Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.

Introduced May 14, 2026
Last action May 14, 2026
Pipeline · Resolution
Step 1
Introduced
May 14, 2026
Step 2
Referred
May 14, 2026
E&C
Step 3
Committee
Step 4
House floor